Changes in treatment and outcomes after creation of a pulmonary embolism response team (PERT), a 10-year analysis.
PERT
Pulmonary embolism
Pulmonary embolism response team
Thrombolysis
Treatment
Journal
Journal of thrombosis and thrombolysis
ISSN: 1573-742X
Titre abrégé: J Thromb Thrombolysis
Pays: Netherlands
ID NLM: 9502018
Informations de publication
Date de publication:
Jan 2019
Jan 2019
Historique:
pubmed:
23
9
2018
medline:
21
3
2019
entrez:
23
9
2018
Statut:
ppublish
Résumé
Multidisciplinary pulmonary embolism response teams (PERTs) are being implemented to improve care of patients with life-threatening PE. We sought to determine how the creation of PERT affects treatment and outcomes of patients with serious PE. A pre- and post-intervention study was performed using an interrupted time series design, to compare patients with PE before (2006-2012) and after (2012-2016) implementation of PERT at a university hospital. T-tests, Chi square tests and logistic regression were used to compare outcomes, and multivariable regression were used to adjust for differences in PE severity. Two-sided p-value < 0.05 was considered significant. For the interrupted time-series analysis, data was divided into mutually exclusive 6-month time periods (11 pre- and 7 post-PERT). To examine changes in treatment and outcomes associated with PERT, slopes and change points were compared pre- and post-PERT. Two-hundred and twelve pre-PERT and 228 post-PERT patients were analyzed. Patient demographics were generally similar, though pre-PERT, PE were more likely to be low-risk (37% vs. 19%) while post-PERT, PE were more likely to be submassive (32% vs. 49%). More patients underwent catheter directed therapy (1% vs. 14%, p = < 0.0001) or any advanced therapy (19 [9%] vs. 44 [19%], p = 0.002) post PERT. Interrupted time series analysis demonstrated that this increase was sudden and coincident with implementation of PERT, and most noticeable among patients with submassive PE. There were no differences in major bleeding or mortality pre- and post-PERT. While the use of advanced therapies, particularly catheter-directed therapies, increased after creation of PERT, especially among patients with submassive PE, there was no apparent increase in bleeding.
Identifiants
pubmed: 30242551
doi: 10.1007/s11239-018-1737-8
pii: 10.1007/s11239-018-1737-8
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
31-40Commentaires et corrections
Type : ErratumIn
Références
Lancet. 1999 Apr 24;353(9162):1386-9
pubmed: 10227218
J Thorac Cardiovasc Surg. 2005 May;129(5):1018-23
pubmed: 15867775
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
J Vasc Interv Radiol. 2009 Nov;20(11):1431-40
pubmed: 19875060
Thromb Haemost. 2011 Apr;105(4):706-11
pubmed: 21225095
J Am Coll Cardiol. 2011 Feb 8;57(6):700-6
pubmed: 21292129
Circulation. 2011 Apr 26;123(16):1788-830
pubmed: 21422387
Crit Care Clin. 2011 Oct;27(4):907-32, vii
pubmed: 22082520
MMWR Morb Mortal Wkly Rep. 2012 Jun 8;61(22):401-4
pubmed: 22672974
Am J Cardiol. 2013 Jan 15;111(2):273-7
pubmed: 23102885
Chest. 2013 Nov;144(5):1738-1739
pubmed: 24189880
Circulation. 2014 Jan 28;129(4):479-86
pubmed: 24226805
J Thromb Haemost. 2014 Apr;12(4):459-68
pubmed: 24484241
Hosp Pract (1995). 2014 Feb;42(1):31-7
pubmed: 24566594
N Engl J Med. 2014 Apr 10;370(15):1402-11
pubmed: 24716681
Thorax. 2014 Sep;69(9):835-42
pubmed: 24846902
Eur Heart J. 2014 Nov 14;35(43):3033-69, 3069a-3069k
pubmed: 25173341
Chest. 2015 Sep;148(3):667-673
pubmed: 25856269
Crit Pathw Cardiol. 2015 Sep;14(3):90-6
pubmed: 26214811
JACC Cardiovasc Interv. 2015 Aug 24;8(10):1382-92
pubmed: 26315743
Circulation. 2016 Jan 5;133(1):98-103
pubmed: 26719388
Chest. 2016 Feb;149(2):315-352
pubmed: 26867832
Chest. 2016 Aug;150(2):384-93
pubmed: 27006156
Thromb Res. 2016 Sep;145:27-33
pubmed: 27442716
Semin Thromb Hemost. 2016 Nov;42(8):857-864
pubmed: 27769084
Chest. 2016 Dec;150(6):1414-1417
pubmed: 27938758
Cardiovasc Diagn Ther. 2016 Dec;6(6):662-667
pubmed: 28123986
Hosp Pract (1995). 2017 Aug;45(3):76-80
pubmed: 28325091